Biopharmaceutical startup Silverback Therapeutics was sued 11 months after going public, with accusations it had overstated the efficacy of one of its products.
source https://www.seattletimes.com/business/shareholders-accuse-seattle-health-startup-of-misleading-investors-after-ipo/?utm_source=RSS&utm_medium=Referral&utm_campaign=RSS_technology
No comments:
Post a Comment